サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1266317

遺伝子検査の世界市場：提供、検査タイプ、方法、エンドユーザー別 - 予測（～2030年）

Genetic Testing Market by Offering, Test Type, Method, End User - Global Forecast to 2030
出版日: | 発行: Meticulous Research | ページ情報: 英文 177 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.24円
遺伝子検査の世界市場：提供、検査タイプ、方法、エンドユーザー別 - 予測（～2030年）
出版日: 2023年04月24日
発行: Meticulous Research
ページ情報: 英文 177 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子検査の市場規模は、2030年までに282億4,000万米ドルに達し、2023年～2030年にCAGRで10.4%の成長が予測されています。市場の成長は、主に遺伝子検査を推進する政府の取り組み、遺伝性疾患の流行、疾患の早期発見と予防に対するニーズの高まり、腫瘍における遺伝子検査の応用の増加、シーケンス処置のコストの低下によって促進されています。

当レポートでは、世界の遺伝子検査市場について調査分析し、市場規模と予測、地域とセグメントの分析、競合情勢などを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の考察

  • 市場の概要
  • 促進要因
  • 抑制要因
  • 機会
  • 課題

第5章 世界の遺伝子検査市場：提供別

  • イントロダクション
  • 消耗品・試薬
  • 器具
  • サービス

第6章 世界の遺伝子検査市場：検査タイプ別

  • イントロダクション
  • 出生前検査
  • 予測・発症前検査
  • 診断検査
  • キャリアー検査
  • 新生児スクリーニング
  • 着床前検査

第7章 世界の遺伝子検査市場：方法別

  • イントロダクション
  • 分子検査
  • 染色体検査
  • 生化学検査

第8章 世界の遺伝子検査市場：エンドユーザー別

  • イントロダクション
  • 病院・診療所
  • 診断検査室
  • その他のエンドユーザー

第9章 遺伝子検査市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • イタリア
    • フランス
    • 英国
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他のアジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • イントロダクション
  • 主な成長戦略
  • 競合ベンチマーキング
  • 市場シェア分析（2022年）
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Myriad Genetics, Inc.
  • 競合ダッシュボード
    • 業界のリーダー
    • 市場の差別化要因
    • 先導企業
    • 新興企業

第11章 企業プロファイル（事業の概要、財務の概要、製品ポートフォリオ、戦略的発展）

  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Perkinelmer Inc.
  • F. Hoffman-La Roche Ltd.
  • Centogene N.V.
  • Konica Minolta, Inc.
  • Opko Health, Inc.
  • Fulgent Genetics, Inc.

第12章 付録

図表

List of Tables

  • Table 1 Global Genetic Testing Market: Impact Analysis of Market Drivers (2023-2030)
  • Table 2 The Middle East: Cystic Fibrosis Birth Incidence, by Country (2018)
  • Table 3 Europe: Number of Patients with Cystic Fibrosis, by Country (2020)
  • Table 4 Asia-Pacific: Number of New Cancer Cases, by Country (2020 Vs. 2030)
  • Table 5 Number of New Cancer Cases, by Type (2020 Vs. 2030)
  • Table 6 Global Genetic Testing Market: Impact Analysis of Market Restraints (2023-2030)
  • Table 7 Global Genetic Testing Market: Impact Analysis of Market Opportunities (2023-2030)
  • Table 8 Global Genetic Testing Market: Impact Analysis of Market Challenges (2023-2030)
  • Table 9 Global Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 10 Global Genetic Testing Market Size for Consumables & Reagents, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global Genetic Testing Market Size for Instruments, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Genetic Testing Market Size for Services, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 14 Global Prenatal Genetic Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Predictive and Presymptomatic Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global Genetic Diagnostic Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Carrier Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global Genetic Testing Market Size for Newborn Screening, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global Preimplantation Genetic Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 21 Global Molecular Genetic Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 22 Global Chromosomal Genetic Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global Biochemical Genetic Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 24 Global Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 25 Global Genetic Testing Market Size for Hospitals and Clinics, by Country/Region, 2021-2030 (USD Million)
  • Table 26 Global Genetic Testing Market Size for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 27 Global Genetic Testing Market Size for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 28 Global Genetic Testing Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 29 North America: Genetic Testing Market Size, by Country, 2021-2030 (USD Million)
  • Table 30 North America: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 31 North America: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 32 North America: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 33 North America: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 34 U.S.: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 35 U.S.: Genetic Testing Market Size, by Test Type 2021-2030 (USD Million)
  • Table 36 U.S.: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 37 U.S.: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 38 Canada: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 39 Canada: Genetic Testing Market Size, by Test Type 2021-2030 (USD Million)
  • Table 40 Canada: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 41 Canada: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 42 Europe: Genetic Testing Market Size, by Country, 2021-2030 (USD Million)
  • Table 43 Europe: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 44 Europe: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 45 Europe: Genetic Testing Market Size, by Method 2021-2030 (USD Million)
  • Table 46 Europe: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 47 Germany: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 48 Germany: Genetic Testing Market Size, by Test Type 2021-2030 (USD Million)
  • Table 49 Germany: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 50 Germany: Genetic Testing Market Size, by End User 2021-2030 (USD Million)
  • Table 51 Italy: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 52 Italy: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 53 Italy: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 54 Italy.: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 55 France: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 56 France: Genetic Testing Market Size, by Test Type 2021-2030 (USD Million)
  • Table 57 France: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 58 France: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 59 U.K.: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 60 U.K.: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 61 U.K.: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 62 U.K.: Genetic Testing Market Size, by End User 2021-2030 (USD Million)
  • Table 63 Spain: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 64 Spain: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 65 Spain: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 66 Spain: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 67 Estimated Number of New Cancer Cases (2030)
  • Table 68 Rest of Europe: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 69 Rest of Europe: Genetic Testing Market Size, by Test Type 2021-2030 (USD Million)
  • Table 70 Rest of Europe: Genetic Testing Market Size, by Method 2021-2030 (USD Million)
  • Table 71 Rest of Europe: Genetic Testing Market, by End User 2021-2030 (USD Million)
  • Table 72 Asia-Pacific: Genetic Testing Market Size, by Country, 2021-2030 (USD Million)
  • Table 73 Asia-Pacific: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 74 Asia-Pacific: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 75 Asia-Pacific: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 76 Asia-Pacific: Genetic Testing Market Size, by End User. 2021-2030 (USD Million)
  • Table 77 Japan: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 78 Japan: Genetic Testing Market Size, by Test Type 2021-2030 (USD Million)
  • Table 79 Japan: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 80 Japan: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 81 China: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 82 China: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 83 China: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 84 China: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 85 India: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 86 India: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 87 India: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 88 India: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 89 Estimated Number of New Cancer Cases in the Rest of Asia-Pacific, by Country (2020 Vs. 2030)
  • Table 90 Rest of Asia-Pacific: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 91 Rest of Asia-Pacific: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 92 Rest of Asia-Pacific: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 93 Rest of Asia-Pacific: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 94 Latin America: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 95 Latin America: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 96 Latin America: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 97 Latin America: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 98 Cystic Fibrosis Birth Incidence in The Middle East
  • Table 99 Middle East and Africa: Genetic Testing Market Size, by Offering, 2021-2030 (USD Million)
  • Table 100 Middle East and Africa: Genetic Testing Market Size, by Test Type, 2021-2030 (USD Million)
  • Table 101 Middle East and Africa: Genetic Testing Market Size, by Method, 2021-2030 (USD Million)
  • Table 102 Middle East and Africa: Genetic Testing Market Size, by End User, 2021-2030 (USD Million)
  • Table 103 Recent Developments, by Company, 2019-2023
目次
Product Code: MRHC - 104686

Genetic Testing Market by Offering (Consumables, Reagents, Instruments, Services), Test Type (Diagnostic, Prenatal, Carrier, Newborn, Preimplantation), Method (Molecular, Chromosomal), End User (Hospitals, Diagnostic Laboratories) - Global Forecast to 2030

The genetic testing market is projected to reach $28.24 billion by 2030, at a CAGR of 10.4% from 2023 to 2030.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growth of this market is mainly driven by government initiatives promoting genetic testing, the increasing prevalence of genetic disorders, the growing need for the early detection & prevention of diseases, the increasing applications of genetic testing in oncology, and the decreasing costs of sequencing procedures. However, the high cost of genetic testing in low-income countries and its social and ethical implications restrain the growth of the genetic testing market. The growing potential of direct-to-consumer genetic testing and the emerging field of genetic counseling are expected to create growth opportunities for the players operating in this market. However, the low chances of positive, actionable mutations and concerns regarding the security & privacy of genetic data are major challenges to market growth.

Based on offering, in 2023, the consumables & reagents segment is expected to account for the largest share of the market. The key factors contributing to the largest market share of the segment are rising demand for genetic testing, recurring demand for consumables and reagents, and use of consumables & reagents by multiple end users such as hospitals, research laboratories, and diagnostic & testing laboratories. The surge in genetic tests at hospitals and diagnostics labs is one of the key factors for the growing demand for consumables and reagents.

Based on test type, in 2023, the prenatal testing segment is expected to account for the largest share of the market. The key factors contributing to the large market share of this segment are the ability of prenatal tests to detect the genetic risks associated with an infant's health. Also, some invasive prenatal tests are conducted when there is a risk of developing genetic abnormalities in infants, such as a neural tube defect or chromosomal abnormality. These factors are expected to fuel the adoption of prenatal genetic tests.

Based on method, the market is segmented into molecular tests, biochemical tests, and chromosomal tests. In 2023, the molecular tests segment is expected to account for the largest share of the market. Several advantages offered by molecular tests such as high accuracy, fewer false positive results, and short test period, support the large market share of this segment. Additionally, increased government funding for the development of advanced molecular testing, increased research activities, and a rise in test frequencies for genetic disorders are leading to the growing demand for molecular testing.

Based on end user, the hospitals & clinics segment is likely to register the highest CAGR over the forecast period. Growing demand for advanced technology in the genetic screening of hereditary cancers, well-established infrastructure, the increasing use of advanced techniques, and the growing prevalence of chronic diseases are some of the major factors leading to the rapid growth of the hospital & clinics segment.

An in-depth analysis of the geographical scenario of the genetic testing market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

In 2023, North America is expected to command the largest share of the genetic testing market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Key factors such as high spending power, the growing importance of early disease diagnosis, government initiatives to increase test frequencies, growing funding for research activities, and high R&D expenditure are responsible for the region's high share of the genetic testing market.

Some of the key players operating in the global genetic testing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), OPKO Health Inc. (U.S.), Natera, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Myriad Genetics, Inc. (U.S.), Centogene N.V. (Germany), Konica Minolta, Inc. (Japan), Fulgent Genetics, Inc. (U.S.), and Laboratory Corporation of America Holdings (U.S.).

Scope of the Report:

Genetic Testing Market, by Offering

  • Consumables & Reagents
  • Instruments
  • Services

Genetic Testing Market, by Test Type

  • Diagnostic Testing
  • Predictive and Presymptomatic Testing
  • Newborn Screening
  • Prenatal Testing
  • Preimplantation Testing
  • Carrier Testing

Genetic Testing Market, by Method

  • Molecular Tests
  • Chromosomal Tests
  • Biochemical Tests

Genetic Testing Market, by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others End Users

(Note: Other End Users Include Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, And Contract Research Organizations)

Genetic Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-up Approach
      • 2.3.1.2. Top-down Approach
      • 2.3.1.3. Growth Forecast
  • 2.4. Assumptions for the study
  • 2.5. Limitations for the study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Government Initiatives Promoting Genetic Testing
    • 4.2.2. Increasing Prevalence of Genetic Disorders
      • 4.2.2.1. Sickle Cell Disease
      • 4.2.2.2. Cystic Fibrosis
      • 4.2.2.3. Down Syndrome and Neural Tube Defects
      • 4.2.2.4. Parkinson's Disease and Alzheimer's Disease
      • 4.2.2.5. Diabetes
    • 4.2.3. Growing Need for the Early Detection & Prevention of Diseases
    • 4.2.4. Increasing Applications of Genetic Testing in Oncology
    • 4.2.5. Decreasing Costs of Sequencing Procedures
  • 4.3. Restraints
    • 4.3.1. High Cost of Genetic Testing in Low-Income Countries
    • 4.3.2. Social and Ethical Implications of Genetic Testing
  • 4.4. Opportunities
    • 4.4.1. Growing Potential of Direct-To-Consumer Genetic Testing
    • 4.4.2. Emerging Field of Genetic Counseling
  • 4.5. Challenges
    • 4.5.1. Low Chances of Positive, Actionable Mutations
    • 4.5.2. Concerns Regarding the Security & Privacy of Genetic Data

5. Global Genetic Testing Market, by Offering

  • 5.1. Introduction
  • 5.2. Consumables & Reagents
  • 5.3. Instruments
  • 5.4. Services

6. Global Genetic Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Prenatal Testing
  • 6.3. Predictive and Presymptomatic Testing
  • 6.4. Diagnostic Testing
  • 6.5. Carrier Testing
  • 6.6. Newborn Screening
  • 6.7. Preimplantation Testing

7. Global Genetic Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Molecular Tests
  • 7.3. Chromosomal Tests
  • 7.4. Biochemical Tests

8. Global Genetic Testing Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals and Clinics
  • 8.3. Diagnostic Laboratories
  • 8.4. Other End Users

9. Genetic Testing Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. Italy
    • 9.3.3. France
    • 9.3.4. U.K.
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (RoE)
  • 9.4. Asia-pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (RoAPAC)
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis (2022)
    • 10.4.1. Illumina, Inc.
    • 10.4.2. Laboratory Corporation of America Holdings
    • 10.4.3. Thermo Fisher Scientific Inc.
    • 10.4.4. Myriad Genetics, Inc.
  • 10.5. Competitive Dashboard
    • 10.5.1. Industry Leaders
    • 10.5.2. Market Differentiators
    • 10.5.3. Vanguards
    • 10.5.4. Emerging Companies

11. Company profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 11.1. Thermo Fisher Scientific Inc.
  • 11.2. Illumina, Inc.
  • 11.3. Laboratory Corporation of America Holdings
  • 11.4. Myriad Genetics, Inc.
  • 11.5. Natera, Inc.
  • 11.6. Perkinelmer Inc.
  • 11.7. F. Hoffman-La Roche Ltd.
  • 11.8. Centogene N.V.
  • 11.9. Konica Minolta, Inc.
  • 11.10. Opko Health, Inc.
  • 11.11. Fulgent Genetics, Inc.

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports